Roche announced the cobas MPX-E assay, a qualitative in‑vitro test that detects and discriminates HIV and hepatitis B, C and E, is now available in countries accepting the CE mark. The CE availability enables commercial distribution across CE jurisdictions; this is a routine product-availability update with limited immediate financial impact.
Roche announced the cobas MPX-E assay, a qualitative in‑vitro test that detects and discriminates HIV and hepatitis B, C and E, is now available in countries accepting the CE mark. The CE availability enables commercial distribution across CE jurisdictions; this is a routine product-availability update with limited immediate financial impact.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
